Press Releases Avalo Therapeutics, Inc.

Equities

AVTX

US05338F3064

Market Closed - Nasdaq Other stock markets 01:30:00 09/05/2024 am IST			5-day change	1st Jan Change
11.73 ^USD	-11.47%		-31.48%	+28.90%

17/04	North American Morning Briefing : Stock Futures -2-	DJ
16/04	Oppenheimer Upgrades Avalo Therapeutics to Outperform From Perform, Price Target is $35	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Avalo Therapeutics Appoints Biotech Leaders to Board of Directors	02/04	AQ
Avalo Reports 2023 Financial Results and Provides Business Updates	01/04	AQ
Avalo Reports 2023 Financial Results and Provides Business Updates	30/03	AQ
Avalo Acquires Anti-IL-1β mAb and Announces Private Placement Financing of up to $185 Million	28/03	AQ
Avalo Therapeutics Announces 1-for-240 Reverse Stock Split	27/12	AQ
Avalo Therapeutics : 2023 Annual Meeting of Stockholders	19/12	PU
Avalo Encourages Stockholders to Vote FOR the Reverse Stock Split	07/12	AQ
Avalo Reports Third Quarter 2023 Financial Results and Provides Business Updates	09/11	AQ
Avalo Completes Divestiture of AVTX-800 Series	31/23/31	AQ
Catheter Precision Inc. (NYSE American: VTAK) Nasdaq/NYSE Stocks Ignite Multiple Buzzers (AVTX, SPCB, INTZ)	11/23/11	AQ
Kaival Brands Innovation Group, Inc. (NASDAQ: KAVL) Global Expansion Generates Revenues w/Philip Morris (NYSE: PM): LIFW, AVTX, NVOS	29/23/29	AQ
BestGrowthStocks.com Issues a Comprehensive Analysis of Avalo Therapeutics	27/23/27	AQ
Avalo Therapeutics Successfully Eliminates $35 Million Debt Paving the Way for Future Growth and Innovation	26/23/26	AQ
Nano-Cap Medical Watchlist (TBRIF, CLRB, AVTX, SISI)	25/23/25	AQ
Avalo Enters into Agreement to Divest AVTX-800 Series	12/23/12	AQ
Avalo Therapeutics : H.C. Wainwright Conference Presentation	07/23/07	PU
Avalo to Present at the H.C. Wainwright 25th Annual Global Investment Conference	06/23/06	AQ
Avalo Reports Second Quarter 2023 Financial Results and Provides Business Updates	03/23/03	AQ
Avalo Therapeutics : July 2023 Investor Presentation	21/23/21	PU
Avalo to Participate in SVB Securities Therapeutics Forum	07/23/07	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Avalo Therapeutics, Inc.

Equities

AVTX

US05338F3064

Press Releases

Filters